Detalhe da pesquisa
1.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
N Engl J Med
; 386(6): 531-543, 2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910859
2.
Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
J Infect Dis
; 228(3): 299-310, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722147
3.
Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.
Am J Respir Crit Care Med
; 205(11): 1290-1299, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290169
4.
AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.
J Infect Dis
; 211(5): 801-10, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25293368
5.
Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial.
Pediatrics
; 150(5)2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214072
6.
A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.
J Infect Dis
; 202(9): 1327-37, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20874515
7.
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6â¯months throughâ¯<18â¯years of age: A randomized controlled phase II dose-finding trial.
Vaccine
; 39(11): 1572-1582, 2021 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33610374
8.
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.
Lancet Infect Dis
; 21(2): 252-262, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946836
9.
Generation of recombinant hyperimmune globulins from diverse B-cell repertoires.
Nat Biotechnol
; 39(8): 989-999, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33859400
10.
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in ≥56-year-olds: A Phase III randomized study.
Vaccine
; 38(28): 4405-4411, 2020 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32387012
11.
Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study.
Hum Vaccin Immunother
; 16(6): 1292-1298, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209015
12.
Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial.
Pediatr Infect Dis J
; 38(3): 323-328, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30395011
13.
Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.
J Pediatric Infect Dis Soc
; 6(1): 9-19, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062552
14.
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial.
Vaccine
; 33(4): 559-67, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25448092
15.
Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.
J Pediatric Infect Dis Soc
; 4(4): 339-48, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26582873
16.
Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
Influenza Other Respir Viruses
; 7(6): 1142-50, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23061976
17.
A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age.
Hum Vaccin Immunother
; 9(9): 1978-88, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23782962
18.
A Phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children.
Pediatr Infect Dis J
; 29(10): 924-30, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20431425
19.
Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.
Vaccine
; 28(50): 7865-72, 2010 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20943209